- Home
- PROC
PROC
Procaps Group S.A.
as 12-20-2024 3:41pm EST
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
| Founded: | 1976 | Country: | Luxembourg |
| Employees: | N/A | City: | N/A |
| Market Cap: | 203.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 136.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.52 | EPS Growth: | -12.90 |
| 52 Week Low/High: | $0.50 - $4.95 | Next Earning Date: | 02-15-2025 |
| Revenue: | $414,096,000 | Revenue Growth: | -4.80% |
| Revenue Growth (this year): | 5.54% | Revenue Growth (next year): | 8.54% |
Latest Procaps Group S.A. News
PROC Breaking Stock News: Dive into PROC Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates
Simply Wall St.
5 days ago
A Look At The Intrinsic Value Of Procaps Group S.A. (NASDAQ:PROC)
GlobeNewswire
19 days ago
Procaps Group Announces Financing, Shareholders Agreement and Board Updates
GlobeNewswire
a month ago
Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing
GlobeNewswire
2 months ago
Procaps Issues Shareholder Letter Update
Simply Wall St.
3 months ago
With 60% ownership, Procaps Group S.A. (NASDAQ:PROC) insiders have a lot riding on the company's future
GlobeNewswire
3 months ago
Procaps Issues Shareholder Letter Update
GlobeNewswire
4 months ago
Procaps Issues Shareholder Letter
Compare PROC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PROC Procaps Group S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.